Alleviant ALLAY-HF Study
NCT: NCT05685303 · ENROLLING_BY_INVITATION
NCT IDNCT05685303
StatusENROLLING_BY_INVITATION
Start Date2023-01-10
Completion2032-12-01
Brief Summary
Prospective, multicenter, randomized, sham-controlled, double blinded, adaptive study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFpEF/HFmrEF.
Frequently Asked Questions
What is Alleviant ALLAY-HF Study?
Alleviant ALLAY-HF Study is a clinical trial registered under NCT05685303. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT05685303?
The current status of NCT05685303 (Alleviant ALLAY-HF Study) is: ENROLLING_BY_INVITATION.
When did Alleviant ALLAY-HF Study start?
Alleviant ALLAY-HF Study started on 2023-01-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.